↓ Skip to main content

Nrf2 as a Potential Mediator of Cardiovascular Risk in Metabolic Diseases

Overview of attention for article published in Frontiers in Pharmacology, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
10 X users
patent
1 patent

Citations

dimensions_citation
128 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Nrf2 as a Potential Mediator of Cardiovascular Risk in Metabolic Diseases
Published in
Frontiers in Pharmacology, April 2019
DOI 10.3389/fphar.2019.00382
Pubmed ID
Authors

Rafael M. da Costa, Daniel Rodrigues, Camila A. Pereira, Josiane F. Silva, Juliano V. Alves, Núbia S. Lobato, Rita C. Tostes

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 111 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 14%
Researcher 13 12%
Student > Master 13 12%
Student > Bachelor 7 6%
Student > Doctoral Student 6 5%
Other 22 20%
Unknown 35 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 30 27%
Medicine and Dentistry 14 13%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Agricultural and Biological Sciences 7 6%
Engineering 7 6%
Other 8 7%
Unknown 37 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 October 2021.
All research outputs
#3,883,097
of 24,083,187 outputs
Outputs from Frontiers in Pharmacology
#1,811
of 17,947 outputs
Outputs of similar age
#78,245
of 356,548 outputs
Outputs of similar age from Frontiers in Pharmacology
#65
of 359 outputs
Altmetric has tracked 24,083,187 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,947 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,548 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 359 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.